Search

Your search keyword '"Egeo A"' showing total 905 results

Search Constraints

Start Over You searched for: Author "Egeo A" Remove constraint Author: "Egeo A"
905 results on '"Egeo A"'

Search Results

53. Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life study

56. Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study

62. Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience

63. Migraine as a Cortical Brain Disorder

64. Applications of Ketogenic Diets in Patients with Headache: Clinical Recommendations

65. Automated pipeline for the analysis of a scale-reduced steel cable net

66. Geometrical digital twinning of a tapered, horizontally curved composite box girder bridge

67. Ambient modal identification applied to a school building in Girona (Spain)

68. ¿Cuánto grande es 'grande' en los movimientos de ladera? Encuesta sobre la idea de magnitud y su comunicación

69. Spatial data infrastructure (SDI) for inventory rockfalls with fragmentation information

70. Capturing rockfall kinematic and fragmentation parameters using high-speed camera system

71. Comparative analysis of a new assessment of the seismic risk of residential buildings of two districts of Barcelona

72. Análisis de susceptibilidad de deslizamientos superficiales a escala regional: efecto de futuros cambios en el Val d’Aran (Pirineo Central)

73. Comunicación de la geoinformación 3D mediante visores web y entornos inmersivos de realidad mixta en problemas de taludes y laderas

74. Simulación de desprendimientos rocosos con fragmentación mediante RockGIS

75. Medida de parámetros cinemáticos de bloques rocosos en un ensayo a escala real

76. Rockfalls: analysis of the block fragmentation through field experiments

77. Impacts of future climate and land cover changes on landslide susceptibility: regional scale modelling in the Val d’Aran region (Pyrenees, Spain)

78. A Framework to Project Future Rainfall Scenarios: An Application to Shallow Landslide-Triggering Summer Rainfall in Wanzhou County China

81. Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients

82. Machine learning approach to predict medication overuse in migraine patients

83. Additional file 1 of Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)

84. Additional file 1 of Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study

85. Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)

86. Association of intronic variants of the KCNAB1 gene with lateral temporal epilepsy

87. Fremanezumab in the Prevention of High-Frequency Episodic and Chronic Migraine: A 12-Week, Multicenter, Real-Life, Cohort Study (The FRIEND Study).

89. Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy: The multicenter prospective cohort GARLIT study.

91. Long-term (>48 weeks) safety and tolerability of erenumab in real-life

92. Fremanezumab in the prevention of high-frequency episodic and chronic migraine: Friend (fremanezumab in real world study), the first Italian multicenter, prospective real-life study

94. Long term (48-weeks) effectiveness, safety and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in real-world: The early 2 study

95. Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)

96. When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway?

97. Clinical features, disease progression and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project

98. Discontinuing Monoclonal Antibodies Targeting CGRP Pathway After One-Year Treatment: An Observational Longitudinal Cohort Study

99. Dopamine-beta-hydroxylase 19-bp insertion/deletion polymorphism affects medication overuse in patients with chronic migraine

Catalog

Books, media, physical & digital resources